Completed
Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to explore opportunities, challenges, and ethical questions surrounding the development, regulation and reimbursement of such devices.
Featured publication
Workshop
ยท2015
Based on advances in biotechnology and neuroscience, non-invasive neuromodulation devices are poised to gain clinical importance in the coming years and to be of increasing interest to patients, clinicians,health systems, payers, and industry. Evidence suggests that both therapeutic and non-therapeu...
View details
Description
An ad hoc committee will plan and conduct a two-day public workshop to explore opportunities, challenges, and ethical questions surrounding therapeutic and non-therapeutic uses of non-invasive neuromodulation of the central nervous system.
Presentations and discussions will be designed to:
- Highlight potential benefits and risks of non-invasive neuromodulation based on known short and long-term central nervous system mechanisms of action
- Explore the scientific landscape of non-invasive neuromodulation device development for both therapeutic and non-therapeutic uses
- Consider issues concerning vulnerable populations such as children
- Explore the scientific landscape of non-invasive neuromodulation device development for both therapeutic and non-therapeutic uses
- Consider the regulatory landscape for non-invasive neuromodulation devices
- Discuss potential outcome measures for therapeutic uses in regulatory processes
- Explore pathways for regulatory approval of therapies utilizing a combination of non-invasive neuromodulation devices and pharmaceuticals
- Discuss differences in regulatory pathways among countries
- Explore current and potential use reimbursement practices for therapeutic use of non-invasive neuromodulation devices
- Explore the evidence base and acceptable therapeutic outcome measures utilized in reimbursement decisions
- Consider economic outcome measures used to determine payer practices
- Explore the evidence base and acceptable therapeutic outcome measures utilized in reimbursement decisions
- Examine ethical questions around the use of non-invasive neuromodulation devices
- Consider ethical issues of off-label and over-the counter use on regulation, reimbursement and patient safety
- Discuss the use of these devices for enhancement in individuals without an impaired baseline
- Consider the implications of involuntary or coercive use (e.g., children, court ordered treatment)
- Consider ethical issues of off-label and over-the counter use on regulation, reimbursement and patient safety
The committee will develop the agenda for the workshop, select and invite speakers and discussants, and moderate the discussions. An individually authored workshop summary will be prepared by a designated rapporteur based on presentations and discussions held during the workshop in accordance with institutional guidelines.
Collaborators
Committee
Jeffrey S. Nye
Co-Chair
Alvaro Pascual-Leone
Co-Chair
Stephen Brannan
Member
William Casebeer
Member
Stephen Cha
Member
Martha Farah
Member
Henry T. Greely
Member
Thomas R. Insel
Member
Daniel C. Javitt
Member
Frances E. Jensen
Member
Walter J. Koroshetz
Member
Jay Kranzler
Member
Anne L. Oaklander
Member
Carlos Pena
Member
Peter Reiner
Member
Rhonda J. Robinson Beale
Member
Justin Sanchez
Member
Roger Sorensen
Member
Sponsors
Department of Health and Human Services
National Science Foundation
Other, Federal
Private: For Profit
Private: Non Profit
Staff
Diana Pankevich
Lead
Clare Stroud
Lead
Major units and sub-units
Institute of Medicine
Lead
Board on Health Sciences Policy
Lead